Bioorganic and Medicinal Chemistry Letters p. 2513 - 2517 (2018)
Update date:2022-08-29
Topics:
More, Kunal N.
Hong, Victor S.
Lee, Ahyeon
Park, Jongsung
Kim, Shin
Lee, Jinho
Pim kinases are promising therapeutic targets for the treatment of hematological cancers. A potent Pim kinase inhibitor 7f, derived from meridianin C, was further optimized by the replacement of 2-aminopyrimidine with substituted benzene. The optimization of the C-3 and C-5 positions of indole yielded compound 43 with improved cellular potency and high selectivity against a panel of 14 different kinases.
View MoreContact:+86-535-8888888
Address:No.161 Haishi Rd.
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Wuhan Konberd Biotech Co., Ltd.
Contact:+86-27-87205925
Address:NO.666, Gaoxin Road, Eastlake High-tech zone
ALPHA PHARMACEUTICAL CO,LTD JIANGSU
Contact:+86-527-84829968,+86-527-84829998
Address:suqian city
Hangzhou Zyter Biological & Chemical Technology Co., Ltd.
website:http://www.zyterpharm.com
Contact:+86-18858184290
Address:West Wenyi Road, Cangqian, Yuhang
Doi:10.1063/1.1607310
(2003)Doi:10.1021/ja01166a518
(1950)Doi:10.1021/jo015798z
(2001)Doi:10.1016/S0040-4039(01)82991-9
(1981)Doi:10.1039/c39800000198
(1980)Doi:10.1246/cl.1982.603
(1982)